NDX-3324

N/A

Report date: 2025/11/18 17:45:27

Base Information

Drug NameNDX-3324

Drug Alias NameNDX-3324

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionDiagnostic imaging enhancers

TargetsUpdating

Therapy Area/IndicationsEosinophilic Esophagitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNexEos Bio

China Registration ClassN/A

Develop Information

Active CompaniesNexEos Bio

Inactive CompaniesN/A

Active IndicationsEosinophilic Esophagitis

Inactive IndicationsN/A

Other Information

ATC CodeN/A